An investigational medication is what is being studied to see if symptoms improve while taking it. It is not yet approved for general use by regulatory authorities. This study uses an investigational medication called Riliprubart. The investigational medicine is injected in a vein or under the skin, either at the …
This study investigates the effects of an investigational medication compared to a placebo in adults with high-risk asthma.The focus of this study is to evaluate the safety, effectiveness, and tolerability of the investigational medication as an add-on therapy. Researchers aim to understand how this treatment works for people who are …
This study investigates the condition known as chronic rhinosinusitis with nasal polyps (CRSwNP). The purpose of this study is to explore the effects of an investigational medication on people with this condition.The study focuses on evaluating the safety, effectiveness, and tolerability of the investigational medication when used with standard nasal …
This study investigates chronic rhinosinusitis with nasal polyps (CRSwNP). The purpose of this study is to evaluate how an investigational medication works when added to standard treatments for people with CRSwNP who are 18 years and older.The focus of the study is to look at the safety, effectiveness, and tolerability …
This study investigates the effects of an investigational medication in adults with relapsing forms of multiple sclerosis. The purpose of this study is to evaluate the safety and effectiveness of the investigational medication. Researchers aim to understand its impact on the annualized relapse rate, which measures how often relapses occur …
This study investigates the effects of an investigational medication on children aged 2 to less than 6 years with uncontrolled asthma or severe asthmatic wheeze. The purpose is to understand how this medication can affect these young patients who have difficulty managing their asthma symptoms.The study focuses on evaluating the …
This study investigates the effectiveness and safety of an investigational medication in treating primary focal segmental glomerulosclerosis (FSGS) or primary minimal change disease (MCD). These conditions affect the kidneys and can lead to nephrotic syndrome, characterized by high levels of protein in the urine.The study aims to evaluate how the …
This study investigates asthma in adults and aims to evaluate the long-term safety and effectiveness of an investigational medication. The focus of the study is to observe how participants respond to the investigational medication over a longer period. The study aims to gather information about the safety and effectiveness of …
This study investigates the safety and ability of an investigational vaccine to produce an immune response in children. It compares the investigational vaccine with two licensed vaccines, focusing on infants aged 11 to 15 months who receive it alongside the Measles Mumps Rubella (MMR) vaccine.The focus of this study is …
This study investigates the effectiveness and safety of an investigational treatment for people aged 12 and older with moderate-to-severe atopic dermatitis (AD). Participants must have had an inadequate response to previous biologic therapy or an oral JAK inhibitor. The study involves using a subcutaneous solution alongside topical corticosteroids.The purpose is …
